Statistics from Altmetric.com
Primary ciliary dyskinesia (PCD) is usually inherited as an autosomal recessive disorder. Affected individuals suffer from recurrent infections of the upper and lower respiratory tract due to reduced mucociliary clearance. Half of the affected offspring exhibit a complete situs inversus because of randomisation of left-right body asymmetry.1,2 The PCD phenotype results from axonemal abnormalities in cilia and flagella. Total or partial absence of dynein arms are found in 70–80% of PCD cases.3
PCD represents a heterogeneous group of genetic disorders. Distinct PCD loci have been mapped to chromosome 9p13-p21 (DNAI1), 19q13.3-qter and 5p15-p14, respectively.4–6 We identified DNAH5 as the gene responsible for PCD located on 5p. DNAH5 encodes a protein highly similar to the Chlamydomonas γ-dynein heavy chain.6 Mutants of the Chlamydomonas orthologue show a slow swimming phenotype and are characterised by axonemal abnormalities consisting of outer dynein arm (ODA) defects.7,8 This phenotype appears similar to that observed in a large Arab family used to map the PCD locus.6 Sequence analysis of the DNAH5 gene in PCD patients with randomisation of left-right asymmetry identified mutations resulting in non-functional DNAH5 proteins.9
The murine orthologue of human DNAH5, called Dnahc5, is predominantly expressed in the lung as shown by Northern blot analysis.9 During gastrulation expression is confined to the node, which explains the randomisation of left-right asymmetry in PCD. Mice with a targeted mutation in Dnahc5 display a phenotype highly similar to that observed in patients with PCD.10Dnahc5 deficient mice develop respiratory symptoms due to reduced mucociliary clearance, and half of the affected offspring have complete situs inversus.
In order to gain insight into the development of the disease phenotype and the function of DNAH5, we have studied the expression of Dnahc5 in the murine respiratory tract in both embryonic and adult tissue of mice using section in situ hybridisation analysis as described previously.9 We found that Dnahc5 expression is confined to ciliated epithelial cells of the upper and lower airways (fig 1A–H). This expression pattern is consistent with the PCD phenotype of humans resulting from mutations in DNAH5 and mice with a targeted disruption of Dnahc5, respectively.9,10 Our expression data strongly suggest that ultrastructural abnormalities resulting from DNAH5 mutations should be present in ciliated respiratory epithelia of the nasopharynx, the larynx, and the bronchi. Sampling of respiratory cilia at different sites of the airway should not therefore affect ultrastructural findings caused by DNAH5 mutations.
Individuals of different PCD families exhibit various degrees of respiratory symptoms. We hypothesised that the severity of the disease phenotype might correlate with the molecular nature of the DNAH5 mutation in a family. Ultrastructural analysis of respiratory cilia in three families carrying homozygous mutations of DNAH5 indicated such a genotype-phenotype correlation. Electron microscopic photographs of respiratory cilia from families F373 and F658 have been reported previously and were compared with ultrastructural findings of the UNC-7 family.7,10 Mutations causing premature translational termination of DNAH5 (1855NfsX5, 2814fsX1) result in a complete absence of all ODA in respiratory cilia (fig1I–K). In contrast, a splice site mutation predicting a loss of exon 75 (IVS74–1G>C) did not cause total absence of ODA. We semiquantitatively assessed ciliary axonemes from the affected siblings of UNC-7 for the presence of ODA in a blinded manner (n=36 cilia for one sibling, n=9 from the other).11 Both siblings had shortened stubby ODA compared with normal. Computer aided quantitative measurement showed that 54% of the ODA were less than half the average length of ODA in normal subjects, which indicates partial ODA deficiency.
We provide evidence for the first genotype-phenotype correlation in PCD. DNAH5 mutations should be considered in individuals with total and partial absence of ODA.
We are grateful to the patients and their families for their participation in this study. This work was supported by the German Research Foundation (DFG) grant Om 6/2-1, Braun Foundation, and UNC grants RR00046 and NIH HL 04225.
The correct order for the authors of this letter is:
A Kispert, H Olbrich, A Volz, U-P Ketelsen, J Horvath, R Melkaoui, M Petry, M Zariwala, P G Noone, M Knowles, H Omran
In the publication the authors are grouped/listed by institution.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.